Author Page for Joanna Reis Santos-Oliveira

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial

Number of pages: 30 Posted: 22 Jan 2021

Vinicius Fontanesi Blum, Sérgio Cimerman, James R. Hunter, Paulo Tierno, Acioly Lacerda, Alexandre Soeiro, Florentino Cardoso, Nancy Cristina Belley, Juliana Maricato, Nathalia Mantovani, Marcella Vassao, Danilo Dias, Juliana Galinskas, Daniel Karcher, Fatima Morgana Pio Fonseca, Renan Novaes Pinto, Luis Mário Ramos Janini, Joanna Reis Santos-Oliveira, Alda Maria Da-Cruz and Ricardo Sobhie Diaz

Federal University of São Paulo (UNIFESP), Institute of Infectious Diseases Emilio Ribas, University of São Paulo (USP) - Division of Infectious Diseases, Hospital Municipal Dr. Francisco Moran, SPDM, INCOR and Beneficência Portuguesa, Hospital Vera Cruz, University of São Paulo (USP) - Division of Infectious Diseases, Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Federal University of São Paulo (UNIFESP), Intituto Federal de Educação - Ciencia e Tecnologia do Rio de Janeiro, Instituto Oswaldo Cruz/FIOCRUZ and University of São Paulo (USP) - Division of Infectious Diseases

Downloads 843 (53,734)

Joanna Reis Santos-Oliveira

Intituto Federal de Educação - Ciencia e Tecnologia do Rio de Janeiro

1

843

1

0

Scholarly Papers (1)

Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial

Abstract: